Conference Coverage: ASCO 2024 – Focus on Genitourinary (GU) Malignancies

Impact of recent ASCO data on clinical practice and therapy guidance in GU cancers

June 11, 2024

Faculty Chair

Daniel Petrylak, MD

Yale University, New Haven, CT, USA


Terence Friedlander, MD
University of California, San Francisco, CA, USA

Mark Tyson, MD, MPH
Mayo Clinic, Phoenix, AZ, USA

David Crawford, MD
University of California, San Diego, CA, USA

Scott Tagawa, MD, FACP, FASCO
Weill Cornell Medicine, New York, NY, USA

Joaquim Bellmunt, MD, PhD
Harvard Medical School, Boston, MA, USA

Thomas Powles, MBBS, MRCP, MD
Barts Cancer Institute, London, UK

Sample Report

Start discovering the insights

View Report


  • Bladder Cancer – Non–Muscle-Invasive Disease
  • Bladder Cancer – Muscle-Invasive Disease
  • Bladder Cancer – Advanced/Metastatic Disease
  • Prostate Cancer – Hormonal, Cytotoxic, and Targeted Therapies
  • Prostate Cancer – Radioligands

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.